CWM
ZBH icon

Catamount Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Catamount Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$121K Buy
+979
New +$111K 0.07% 60

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Catamount Wealth Management's ZBH Position: Q1 2019 in Review

Catamount Wealth Management opened a new position in Zimmer Biomet (ZBH) in Q1 2019: 979 shares worth $121K. The stake represents 0.07% of the portfolio and ranks #60 among its holdings.

896 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

  • Catamount Wealth Management held 979 shares of Zimmer Biomet worth $121K as of Q1 2019.
  • Zimmer Biomet was a new Catamount Wealth Management position in Q1 2019.
  • Zimmer Biomet made up 0.07% of Catamount Wealth Management's portfolio in Q1 2019, its #60 holding.
  • 896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on Catamount Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.